11 citations · 12 across the 3 of their papers we have counts for
4 papers
Challenges and Opportunities in Statistical Analyses and Designs for Neuroscience Clinical Trials
Jia Jia, Man Jin, Bo Lu +10
Drug development is a complex, costly, and high-risk process, with neuroscience representing one of the most challenging therapeutic areas due to the complexity of neurodegenerativ…
Evidence synthesis with reconstructed survival data
Chenqi Fu, Shouhao Zhou, Xuelin Huang +3
We present a general approach to synthesizing evidence of time-to-event endpoints in meta-analyses of aggregate data (AD). Our work goes beyond most previous meta-analytic research…
Meta-analysis of Censored Adverse Events
Xinyue Qi, Shouhao Zhou, Christine B. Peterson +4
Meta-analysis is a powerful tool for assessing drug safety by combining treatment-related toxicological findings across multiple studies, as clinical trials are typically underpowe…
A Note on Bayesian Modeling Specification of Censored Data in JAGS
Xinyue Qi, Shouhao Zhou, Martyn Plummer
Just Another Gibbs Sampling (JAGS) is a convenient tool to draw posterior samples using Markov Chain Monte Carlo for Bayesian modeling. However, the built-in function dinterval() t…